Crossingbridge Advisors, LLC: JACS position timeline

Crossingbridge Advisors, LLC held 312,381 JACS shares at 2026-06-30 per its 13F-HR filed 2026-08-13.

the latest 13F is the newest step

1. period ended2026-06-30

   13F 312,381 shares

   Change vs previous 13F -15,017 shares

   0.59% of the 13F portfolio, value $3,323,734.

   13F-HR 0001104659-26-095580 filed by Crossingbridge Advisors, LLC
   Filed 2026-08-13 (acceptance time not in the bulk data set), ingested 2026-10-06 09:57:27 UTC

   Acceptance time not in the bulk data set (spec §4.2).

2. period ended2026-03-31

   13F 327,398 shares

   Change vs previous 13F +327,381 shares

   0.63% of the 13F portfolio, value $3,466,394.

   13F-HR 0001104659-26-060737 filed by Crossingbridge Advisors, LLC
   Filed 2026-05-14 (acceptance time not in the bulk data set), ingested 2026-10-06 09:58:43 UTC

   Acceptance time not in the bulk data set (spec §4.2).

3. period ended2025-12-31

   13F 17 shares

   Change vs previous 13F +17 shares

   <0.01% of the 13F portfolio, value $177.

   13F-HR 0001104659-26-014810 filed by Crossingbridge Advisors, LLC
   Filed 2026-02-13 (acceptance time not in the bulk data set), ingested 2026-10-07 03:01:36 UTC

   Acceptance time not in the bulk data set (spec §4.2).

4. period ended2025-06-30

   13F 0 shares

   Change vs previous 13F -350,000 shares

   13F-HR 0001104659-25-077288 filed by Crossingbridge Advisors, LLC
   Filed 2025-08-13 (acceptance time not in the bulk data set), ingested 2026-10-07 18:23:11 UTC

   Acceptance time not in the bulk data set (spec §4.2).

   Exited: the 13F for this period no longer lists the position.

5. period ended2025-03-31

   13F 350,000 shares

   Change vs previous 13F not available

   0.66% of the 13F portfolio, value $1,257,000.

   13F-HR 0001104659-25-048296 filed by Crossingbridge Advisors, LLC
   Filed 2025-05-14 (acceptance time not in the bulk data set), ingested 2026-10-07 18:25:06 UTC

   Acceptance time not in the bulk data set (spec §4.2).